Cordectomy as final treatment option for diffuse intramedullary malignant glioma using 5-ALA fluorescence-guided resection

Clinical Neurology and Neurosurgery

Volumn 112, Issue 4, 2010, Pages 357-361

  Ewelt, Christian ^a,b   Stummer, Walter ^b   Klink, Barbara ^a   Felsberg, Jörg ^a   Steiger, Hans Jakob ^a   Sabel, Michael ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

5 Aminolevulinic acid; Cordectomy; Malignant spinal glioma; Neurooncology; Neurosurgery; Resection

Indexed keywords

AMINOLEVULINIC ACID; ANALGESIC AGENT; DIPYRONE; MORPHINE SULFATE; TEMOZOLOMIDE;

ADULT; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CASE REPORT; DYSESTHESIA; FEMALE; FLUORESCENCE; GAIT DISORDER; GLIOBLASTOMA; HUMAN; MOTOR PERFORMANCE; PAIN; PARAPLEGIA; SPASTIC PARAPLEGIA; SPINAL ROOT; TUMOR GROWTH;

ADULT; AMINOLEVULINIC ACID; ASTROCYTOMA; CORDOTOMY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROSURGICAL PROCEDURES; PAIN; PARAPLEGIA; SPINAL CORD NEOPLASMS; SPINE; SURGERY, COMPUTER-ASSISTED;

EID: 77950051373     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2009.12.013     Document Type: Article

References (15)

1. Alvisi C., Cerisoli M., and Giulioni M. Intramedullary spinal gliomas: long-term results of surgical treatments. Acta Neurochir (Wien) 70 3-4 (1984) 169-179
2. Ciappetta P., Salvati M., Capoccia G., Artico M., Raco A., and Fortuna A. Spinal glioblastomas: report of seven cases and review of the literature. Neurosurgery 28 February (2) (1991) 302-306
3. Cohen A.R., Wisoff J.H., Allen J.C., and Epstein F. Malignant astrocytomas of the spinal cord. J Neurosurg 70 January (1) (1989) 50-54
4. Grant W.E., Hopper C., MacRobert A.J., Speight M., and Bown S.G. Photodynamic therapy of oral cancer: photosensitization with systemic aminolaevulinic acid. Lancet 342 (1993) 147-148
5. Kao C.C., and Chang L.W. The mechanism of spinal cord cavitation following spinal cord transaction. Part I: A correlated histochemical study. J Neurosurg 46 (1977) 197-209
6. Kao C.C., Chang L.W., and Bloodworth J.M.B. The mechanism of spinal cord cavitation following spinal cord transaction. Part II: Electron microscope observations. J Neurosurg 46 (1977) 745-756
7. Kriegmair M., Baumgartner R., Knüchel R., Stepp H., Hofstädter F., and Hofstetter A. Detection of early bladder cancer by 5-aminolevulinic acic induced porphyrin fluorescence. J Urol 155 (1996) 105-109
8. Kyoshima K., Ito K., Tanabe A., Iwashita T., Goto T., Sato A., et al. Malignant astrocytoma of the conus medullaris treated by spinal cordectomy. J Clin Neurosci 9 (2002) 211-216
9. Laxton A.W., and Perrin R.G. Cordectomy for the treatment of posttraumatic syringomyelia. J Neurosurg Spine 4 (2006) 174-178
10. Marchan E.M., Sekula Jr. R.F., Jannetta P.J., and Quigley M.R. Long-term survival enhanced by cordectomy in a patient with a spinal glioblastoma multiforme and paraplegia. Case report. J Neurosurg Spine 7 December (6) (2007) 656-659
11. Raco A., Esposito V., Lenzi J., Piccirilli M., Delfini R., and Cantore G. Long-term follow-up of intramedullary spinal cord tumors: a series of 202 cases. Neurosurgery 56 May (5) (2005) 972-981
12. Raza S.M., Anderson W.S., Eberhart C.G., Wolinsky J.P., and Gokaslan Z.L. The application of surgical cordectomy in the management of an intramedullary-extramedullary atypical meningioma: case report and literature review. J Spinal Disord Technol 18 (2005) 449-454
13. Regula J., MacRobert A.J., Gorchein A., Buonaccorsi G.A., Thorpe S.M., Spencer G.M., et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal and colorectal tumours using 5-aminolaevulinic acid induced protoporphyrin IX-a pilot study. Gut 36 (1995) 67-75
14. Shimizu S., Utsuki S., Sato K., Oka H., Fujii K., and Mii K. Photodynamic diagnosis in surgery for spinal ependymoma. Case illustration. J Neurosurg Spine 5 October (4) (2006) 380
15. Stummer W., Pichlmeier U., Meinel T., Wiestler O.D., Zanella F., Reulen H.J., and ALA-Glioma Study Group. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7 May (5) (2006) 392-401